檢索結果 - Kosuke Hashimoto
- Showing 1 - 20 results of 23
- Go to Next Page
-
1
-
2
-
3
Attention network for predicting T-cell receptor–peptide binding can associate attention with interpretable protein structural properties 由 Kyohei Koyama, Kyohei Koyama, Kyohei Koyama, Kosuke Hashimoto, Chioko Nagao, Kenji Mizuguchi, Kenji Mizuguchi, Kenji Mizuguchi
發表在 Frontiers in Bioinformatics (2023-12-01)獲取全文
Article -
4
Integrating spatial and chemical information enhances differentiation of non-alcoholic steatohepatitis states in Raman imaging 由 Ryoya Kondo, Yuta Mizuno, Kentaro Mochizuki, Kosuke Hashimoto, Jean-Emmanuel Clément, Yasuaki Kumamoto, Katsumasa Fujita, Yoshinori Harada, Tamiki Komatsuzaki
發表在 Scientific Reports (2025-10-01)獲取全文
Article -
5
-
6
Correlation between T cell immunity and the duration of EGFR-TKI resistance acquisition in patients harboring EGFR mutations 由 Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi, Ayako Shiono, Yu Miura, Kosuke Hashimoto, Satoshi Yamasaki, Fuyumi Nishihara, Hisao Imai, Kunihiko Kobayashi, Hiroshi Kagamu
發表在 Cancer Immunology, Immunotherapy (2025-07-01)獲取全文
Article -
7
Different incidence of interstitial lung disease according to different kinds of EGFR‐tyrosine kinase inhibitors administered immediately before and/or after anti‐PD‐1 antibodies i... 由 Takahiro Uchida, Kyoichi Kaira, Ou Yamaguchi, Atsuto Mouri, Ayako Shiono, Yu Miura, Kosuke Hashimoto, Fuyumi Nishihara, Yoshitake Murayama, Kunihiko Kobayashi, Hiroshi Kagamu
發表在 Thoracic Cancer (2019-04-01)獲取全文
Article -
8
Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non‐small cell lung cancer patients 由 Ayako Shiono, Kyoichi Kaira, Atsuto Mouri, Ou Yamaguchi, Kosuke Hashimoto, Takahiro Uchida, Yu Miura, Fuyumi Nishihara, Yoshitake Murayama, Kunihiko Kobayashi, Hiroshi Kagamu
發表在 Thoracic Cancer (2019-04-01)獲取全文
Article -
9
Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers 由 Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Shun Shinomiya, Tomoe Akagami, Hisao Imai, Kunihiko Kobayashi, Hiroshi Kagamu
發表在 Frontiers in Oncology (2021-03-01)獲取全文
Article -
10
Pretreatment body mass index predicts survival among patients administered nivolumab monotherapy for pretreated non‐small cell lung cancer 由 Hisao Imai, Erika Naito, Ou Yamaguchi, Kosuke Hashimoto, Hidetoshi Iemura, Yu Miura, Ayako Shiono, Atsuto Mouri, Kyoichi Kaira, Kunihiko Kobayashi, Hiroshi Kagamu
發表在 Thoracic Cancer (2022-05-01)獲取全文
Article -
11
Clinicopathological impact of VEGFR2 and VEGF‐C in patients with EGFR‐major mutant NSCLC receiving osimertinib 由 Kyoichi Kaira, Hisao Imai, Atsuto Mouri, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Ou Yamaguchi, Kunihiko Kobayashi, Tomonori Kawasaki, Masanori Yasuda, Hiroshi Kagamu
發表在 Thoracic Cancer (2023-10-01)獲取全文
Article -
12
Prognostic relevance of TROP2 expression in patients with non-small cell lung cancer receiving immunotherapy 由 Naohito Hashimoto, Shota Takei, Kyoichi Kaira, Hisao Imai, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Ou Yamaguchi, Atsuto Mouri, Kunihiko Kobayashi, Mei Hamda, Hiroshi Kagamu
發表在 Scientific Reports (2025-10-01)獲取全文
Article -
13
Radiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab 由 Ou Yamaguchi, Kyoichi Kaira, Kosuke Hashimoto, Atsuto Mouri, Yu Miura, Ayako Shiono, Fuyumi Nishihara, Yoshitake Murayama, Shin‐ei Noda, Shingo Kato, Kunihiko Kobayashi, Hiroshi Kagamu
發表在 Thoracic Cancer (2019-04-01)獲取全文
Article -
14
Analysis of splice variants of the human protein disulfide isomerase (P4HB) gene 由 Daniela Kajihara, Chung-Chau Hon, Aimi Naim Abdullah, João Wosniak, Ana Iochabel S. Moretti, Joice F. Poloni, Diego Bonatto, Kosuke Hashimoto, Piero Carninci, Francisco R. M. Laurindo
發表在 BMC Genomics (2020-11-01)獲取全文
Article -
15
Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancer 由 Satoshi Endo, Hisao Imai, Atsuto Mouri, Kasumi Tsukamoto, Kenji Masaki, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Ou Yamaguchi, Junichi Nakagawa, Kyoichi Kaira, Kunihiko Kobayashi, Hiroshi Kagamu
發表在 Journal of Cancer Research and Clinical Oncology (2025-01-01)獲取全文
Article -
16
A Real‐Word Analysis of the Correlation Between Clinical Efficacy and Predictive Factors of Immune‐Related Adverse Events in Patients With Nonsmall Lung Cancer Treated With Nivolum... 由 Atsuto Mouri, Hisao Imai, Satoshi Endo, Junichi Nakagawa, Kasumi Tsukamoto, Yuhei Kurata, Ou Yamaguchi, Kenji Masaki, Kosuke Hashimoto, Ayako Shiono, Yu Miura, Kunihiko Kobayashi, Kyoichi Kaira, Hiroshi Kagamu
發表在 Cancer Medicine (2025-04-01)獲取全文
Article -
17
Efficacy and Safety of First-Line Nivolumab Plus Ipilimumab in Patients with Postoperative Recurrent and Inoperable Non-Small Cell Lung Cancer: A Real-World Retrospective Observati... 由 Yuhei Kurata, Atsuto Mouri, Hisao Imai, Satoshi Endo, Kasumi Tsukamoto, Kenji Masaki, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Ou Yamaguchi, Junichi Nakagawa, Kyoichi Kaira, Kunihiko Kobayashi, Hiroshi Kagamu
發表在 Medicina (2025-05-01)獲取全文
Article -
18
Eosinophils as predictive biomarkers in anti-programmed cell death 1 monotherapy for non-small cell lung cancer 由 Takahiro Uchida, Takahiro Uchida, Kazuyuki Nakagome, Kosuke Hashimoto, Hidetoshi Iemura, Yuki Shiko, Atsuto Mouri, Ou Yamaguchi, Yoshitaka Uchida, Yoshiaki Nagai, Tomoyuki Soma, Kyoichi Kaira, Makoto Nagata, Hiroshi Kagamu
發表在 Frontiers in Immunology (2025-10-01)獲取全文
Article -
19
Metachronous lesions in the orbit, retroperitoneum, and pleura of mucosa‐associated lymphoid tissue lymphoma: A case report 由 Ayako Shiono, Hisao Imai, Tsugumi Satou, Ryo Taguchi, Naoki Takahashi, Ryuichi Azuma, Ou Yamaguchi, Kosuke Hashimoto, Erika Naito, Hidetoshi Iemura, Yu Miura, Atsuto Mouri, Kyoichi Kaira, Kunihiko Kobayashi, Hiroshi Kagamu
發表在 Cancer Reports (2022-10-01)獲取全文
Article -
20
Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non‐small cell lung cancer: Management of adverse events 由 Yu Miura, Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi, Ayako Shiono, Kosuke Hashimoto, Fuyumi Nishihara, Shun Shinomiya, Tomoe Akagami, Yoshitake Murayama, Takanori Abe, Shin‐ei Noda, Shingo Kato, Kunihiko Kobayashi, Hiroshi Kagamu
發表在 Thoracic Cancer (2020-05-01)獲取全文
Article
